Insider Transactions for Principia Biopharma Inc. (PRNB)

Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Goldstein David M Chief Scientific Officer Aug 10, 2020 Option Exercise $3.11 6,000 18,632 37,739 Aug 12, 2020, 08:01 PM
Goldstein David M Chief Scientific Officer Aug 10, 2020 Sale $88.61 6,000 531,665 36,881 Aug 12, 2020, 08:01 PM
Thomas Dolca Chief Medical Officer Jul 15, 2020 Option Exercise $23.77 15,000 356,550 16,826 Jul 17, 2020, 08:01 PM
Thomas Dolca Chief Medical Officer Jul 15, 2020 Sale $80.07 15,000 1,201,069 1,826 Jul 17, 2020, 08:01 PM
Colowick Alan Director Jul 01, 2020 Option Exercise $4.54 7,500 34,065 7,500 Jul 02, 2020, 08:48 PM
Colowick Alan Director Jul 01, 2020 Sale $60.00 7,500 450,000 0 Jul 02, 2020, 08:48 PM
Babler Martin President, CEO Jun 23, 2020 Option Exercise $3.00 15,000 44,965 15,810 Jun 25, 2020, 08:07 PM
Babler Martin President, CEO Jun 23, 2020 Sale $61.86 15,000 927,889 15,295 Jun 25, 2020, 08:07 PM
Wolff Stefani Chief Development Officer Jun 15, 2020 Sale $60.75 5,504 334,385 24,200 Jun 17, 2020, 09:52 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale $46.15 5,504 254,031 28,350 Jun 17, 2020, 09:48 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale $49.43 5,505 272,091 31,404 Jun 17, 2020, 09:41 PM
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Option Exercise $4.72 5,000 23,618 122,761 Jun 15, 2020, 08:12 PM
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Sale $61.16 5,000 305,788 121,166 Jun 15, 2020, 08:12 PM
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Option Exercise $3.00 5,675 17,012 11,039 May 21, 2020, 08:01 PM
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Sale $65.10 7,500 488,268 3,539 May 21, 2020, 08:01 PM
Goldstein David M Chief Scientific Officer May 07, 2020 Option Exercise $3.00 6,000 17,986 36,968 May 08, 2020, 08:05 PM
Goldstein David M Chief Scientific Officer May 07, 2020 Sale $60.16 6,000 360,941 33,687 May 08, 2020, 08:05 PM
Colowick Alan Director May 01, 2020 Option Exercise $4.54 840 3,815 840 May 05, 2020, 08:07 PM
Colowick Alan Director May 05, 2020 Option Exercise $4.54 6,660 30,250 6,660 May 05, 2020, 08:07 PM
Colowick Alan Director May 01, 2020 Sale $60.07 840 50,457 0 May 05, 2020, 08:07 PM
Colowick Alan Director May 05, 2020 Sale $60.00 6,660 399,600 0 May 05, 2020, 08:07 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Option Exercise $4.54 5,504 24,999 41,113 Mar 18, 2020, 05:08 PM
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale $46.15 5,504 254,031 39,359 Mar 18, 2020, 05:08 PM
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Option Exercise $4.72 5,000 23,618 121,903 Mar 17, 2020, 05:08 PM
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Sale $48.56 5,000 242,816 118,184 Mar 17, 2020, 05:08 PM
Babler Martin President, CEO Mar 03, 2020 Sale $63.47 15,000 952,083 52,094 Mar 05, 2020, 05:21 PM
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Option Exercise $3.00 2,500 7,494 12,266 Feb 20, 2020, 05:02 PM
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Sale $65.89 7,500 494,186 9,582 Feb 20, 2020, 05:02 PM
Goldstein David Chief Scientific Officer Feb 10, 2020 Option Exercise $3.00 6,000 17,986 36,968 Feb 12, 2020, 07:03 PM
Goldstein David Chief Scientific Officer Feb 10, 2020 Sale $70.90 6,000 425,400 36,168 Feb 12, 2020, 07:03 PM
Thomas Dolca Chief Medical Officer Dec 19, 2019 Sale $60.00 495 29,700 494 Dec 20, 2019, 09:00 PM
Babler Martin President, CEO Dec 18, 2019 Sale $53.66 4,500 241,459 19,196 Dec 19, 2019, 09:06 PM
Babler Martin President, CEO Dec 17, 2019 Sale $52.96 25,000 1,323,996 73,339 Dec 19, 2019, 09:06 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Option Exercise $4.54 5,505 25,004 41,114 Dec 18, 2019, 07:09 PM
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale $49.43 5,505 272,091 36,909 Dec 18, 2019, 07:09 PM
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Option Exercise $4.95 5,000 24,743 125,143 Dec 13, 2019, 08:04 PM
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Sale $49.41 5,000 247,034 121,762 Dec 13, 2019, 08:04 PM
Becker Daniel J. Director Nov 20, 2019 Buy $29.94 55,000 1,646,700 667,600 Nov 22, 2019, 08:07 PM
Goldstein David Chief Scientific Officer Nov 07, 2019 Option Exercise $1.88 10,000 18,815 39,819 Nov 08, 2019, 09:01 PM
Goldstein David Chief Scientific Officer Nov 07, 2019 Sale $32.39 10,000 323,914 29,819 Nov 08, 2019, 09:01 PM
Becker Daniel J. Director Oct 29, 2019 Buy $33.98 9,196 312,477 612,600 Oct 30, 2019, 04:16 PM
Becker Daniel J. Director Oct 28, 2019 Buy $33.41 68,404 2,285,549 603,404 Oct 30, 2019, 04:16 PM
GLAXOSMITHKLINE PLC Former 10% Owner Oct 18, 2019 Buy $28.00 357,142 9,999,976 2,982,855 Oct 22, 2019, 05:36 PM
George Simeon Director Oct 18, 2019 Buy $28.00 357,142 9,999,976 2,982,855 Oct 22, 2019, 04:11 PM
Becker Daniel J. Director Oct 18, 2019 Buy $28.00 535,000 14,980,000 535,000 Oct 22, 2019, 04:06 PM
New Leaf Ventures II, L.P. 10% Owner Aug 13, 2019 Sale $35.00 300,000 10,500,000 1,938,167 Aug 15, 2019, 04:47 PM
ORBIMED ADVISORS LLC 10% Owner May 21, 2019 Sale $30.25 1,000,000 30,250,000 1,605,713 May 22, 2019, 12:43 PM
Sofinnova Venture Partners VIII, L.P. 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,038,208 Sep 20, 2018, 07:02 PM
ORBIMED ADVISORS LLC 10% Owner Sep 18, 2018 Buy $17.00 250,000 4,250,000 2,605,713 Sep 20, 2018, 06:59 PM
Becker Daniel J. Director Sep 18, 2018 Buy $17.00 270,000 4,590,000 437,537 Sep 20, 2018, 06:58 PM
New Leaf Ventures II, L.P. 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 437,537 Sep 20, 2018, 06:53 PM
George Simeon Director Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,625,713 Sep 20, 2018, 06:50 PM
GLAXOSMITHKLINE PLC 10% Owner Sep 18, 2018 Buy $17.00 270,000 4,590,000 2,625,713 Sep 20, 2018, 05:18 PM
AKKARAJU SRINIVAS Director Sep 18, 2018 Buy $17.00 175,000 2,975,000 383,480 Sep 20, 2018, 04:14 PM

Desktop Version

Owner Relationship Date Transaction Value($)
Goldstein David M Chief Scientific Officer Aug 10, 2020 Option Exercise 18,632
Goldstein David M Chief Scientific Officer Aug 10, 2020 Sale 531,665
Thomas Dolca Chief Medical Officer Jul 15, 2020 Option Exercise 356,550
Thomas Dolca Chief Medical Officer Jul 15, 2020 Sale 1,201,069
Colowick Alan Director Jul 01, 2020 Option Exercise 34,065
Colowick Alan Director Jul 01, 2020 Sale 450,000
Babler Martin President, CEO Jun 23, 2020 Option Exercise 44,965
Babler Martin President, CEO Jun 23, 2020 Sale 927,889
Wolff Stefani Chief Development Officer Jun 15, 2020 Sale 334,385
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale 254,031
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale 272,091
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Option Exercise 23,618
Hardiman Roy C. Chief Business Officer Jun 12, 2020 Sale 305,788
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Option Exercise 17,012
CHAI CHRISTOPHER Y Chief Financial Officer May 19, 2020 Sale 488,268
Goldstein David M Chief Scientific Officer May 07, 2020 Option Exercise 17,986
Goldstein David M Chief Scientific Officer May 07, 2020 Sale 360,941
Colowick Alan Director May 01, 2020 Option Exercise 3,815
Colowick Alan Director May 05, 2020 Option Exercise 30,250
Colowick Alan Director May 01, 2020 Sale 50,457
Colowick Alan Director May 05, 2020 Sale 399,600
Wolff Stefani Chief Development Officer Mar 16, 2020 Option Exercise 24,999
Wolff Stefani Chief Development Officer Mar 16, 2020 Sale 254,031
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Option Exercise 23,618
Hardiman Roy C. Chief Business Officer Mar 13, 2020 Sale 242,816
Babler Martin President, CEO Mar 03, 2020 Sale 952,083
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Option Exercise 7,494
CHAI CHRISTOPHER Y Chief Financial Officer Feb 18, 2020 Sale 494,186
Goldstein David Chief Scientific Officer Feb 10, 2020 Option Exercise 17,986
Goldstein David Chief Scientific Officer Feb 10, 2020 Sale 425,400
Thomas Dolca Chief Medical Officer Dec 19, 2019 Sale 29,700
Babler Martin President, CEO Dec 18, 2019 Sale 241,459
Babler Martin President, CEO Dec 17, 2019 Sale 1,323,996
Wolff Stefani Chief Development Officer Dec 16, 2019 Option Exercise 25,004
Wolff Stefani Chief Development Officer Dec 16, 2019 Sale 272,091
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Option Exercise 24,743
Hardiman Roy C. Chief Business Officer Dec 13, 2019 Sale 247,034
Becker Daniel J. Director Nov 20, 2019 Buy 1,646,700
Goldstein David Chief Scientific Officer Nov 07, 2019 Option Exercise 18,815
Goldstein David Chief Scientific Officer Nov 07, 2019 Sale 323,914
Becker Daniel J. Director Oct 29, 2019 Buy 312,477
Becker Daniel J. Director Oct 28, 2019 Buy 2,285,549
GLAXOSMITHKLINE PLC Former 10% Owner Oct 18, 2019 Buy 9,999,976
George Simeon Director Oct 18, 2019 Buy 9,999,976
Becker Daniel J. Director Oct 18, 2019 Buy 14,980,000
New Leaf Ventures II, L.P. 10% Owner Aug 13, 2019 Sale 10,500,000
ORBIMED ADVISORS LLC 10% Owner May 21, 2019 Sale 30,250,000
Sofinnova Venture Partners VIII, L.P. 10% Owner Sep 18, 2018 Buy 4,590,000
ORBIMED ADVISORS LLC 10% Owner Sep 18, 2018 Buy 4,250,000
Becker Daniel J. Director Sep 18, 2018 Buy 4,590,000
New Leaf Ventures II, L.P. 10% Owner Sep 18, 2018 Buy 4,590,000
George Simeon Director Sep 18, 2018 Buy 4,590,000
GLAXOSMITHKLINE PLC 10% Owner Sep 18, 2018 Buy 4,590,000
AKKARAJU SRINIVAS Director Sep 18, 2018 Buy 2,975,000